Celiac disease and hepatitis C relationships in transcriptional regulatory networks. 2017

Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

OBJECTIVE we mainly aimed to elucidate potential comorbidities between celiac disease and hepatitis c by means of data and network analysis approaches. BACKGROUND understanding the association among the disorders evidently has important impact on the diagnosis and therapeutic approaches. Celiac disease is the most challenging, common types of autoimmune disorders. On the other hand, hepatitis c virus genome products like some proteins are supposed to be resemble to gliadin types that in turn activates gluten intolerance in people with inclined to gluten susceptibilities. Moreover, a firm support of association between chronic hepatitis and celiac disease remains largely unclear. Henceforth exploring cross-talk among these diseases will apparently lead to the promising discoveries concerning important genes and regulators. METHODS 321 and 1032 genes associated with celiac disease and hepatitis c retrieved from DisGeNET were subjected to build a gene regulatory network. Afterward a network-driven integrative analysis was performed to exploring prognosticates genes and related pathways. RESULTS 105 common genes between these diseases included 11 transcription factors were identified as hallmark molecules where by further screening enriched in biological GO terms and pathways chiefly in immune systems and signaling pathways such as chemokines, cytokines and interleukins. CONCLUSIONS in silico data analysis approaches indicated that the identified selected combinations of genes covered a wide range of known functions triggering the inflammation implicated in these diseases.

UI MeSH Term Description Entries

Related Publications

Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
September 2018, Scientific reports,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
August 2003, Trends in genetics : TIG,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
January 2016, Gastroenterology and hepatology from bed to bench,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
January 2020, EXCLI journal,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
July 2005, Genes & development,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
December 2002, BioEssays : news and reviews in molecular, cellular and developmental biology,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
December 2008, Current opinion in genetics & development,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
January 2007, Novartis Foundation symposium,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
March 2018, Molecular systems biology,
Fereshteh Izadi, and Mostafa Rezaei Tavirani, and Zahra Honarkar, and Mohammad Rostami-Nejad
November 2008, Current drug targets,
Copied contents to your clipboard!